NurExone Biologic Inc. funding
NurExone Biologic Inc., a biotechnology company based in Technion City, Haifa, Israel (founded 2025), filed a Form D with the SEC on August 21, 2026 and reported $450K raised. It filed 3 new offerings in this period, totaling $1.2M.
Amount raised$450K
Offering size$450K
Filed with the SECAugust 21, 2026
First saleAugust 20, 2026
IndustryBiotechnology
SecuritiesEquity, Options or warrants, Security to be acquired on exercise
LocationTechnion City, Haifa, Israel
Founded2025
Entity typeCorporation
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Aug 21
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| August 21, 2026 | $450K | $450K | Equity, Options or warrants, Security to be acquired on exercise |
| July 2, 2026 | $442K | $442K | Equity, Options or warrants, Security to be acquired on exercise |
| March 18, 2026 | $280K | $280K | Equity, Options or warrants, Security to be acquired on exercise |
Other health care rounds
Lisata Therapeutics, Inc.$352M · Oct 2BiotechnologyPrecision Neuroscience Corp$250M · Sep 28Other Health CareZai Lab Ltd$250M · Nov 9BiotechnologyAmerican Republic Insurance Co.$95M · Oct 22Health InsuranceBridge To Life Ltd.$82.5M · Oct 21Other Health CareAlpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyTypewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology